Resp Part 1 Flashcards
Beta 2 agonists, anti-muscarinincs, ICS, oral corticosteroids
Indications of β2-agonists (short-acting and long-acting)?
Asthma:
- SABA (relieve breathlessness)
- LABA (used alongside ICS for chronic asthma; ALWAYS give LABA with ICS)
COPD:
- SABA (relieve breathlessness)
- LABA (2ND LINE to reduce exacerbations + improve symptoms)
Hyperkalaemia
- nebulised salbutamol
Mechanism of action of β2-agonists?
Activates beta2 receptors in smooth muscle of bronchi/gut/uterus/blood vessels.
→ stimulates GPCR (G protein-coupled receptor) signalling cascade.
→ causes smooth muscle relaxation.
→ As a result, improves airflow in constricted airways and reduces breathlessness.
β2-agonists stimulate Na/K ATPase pumps.
→ causes K+ to move from outside of cells to inside.
Examples of SABA?
Salbutamol
Terbutaline
Examples of LABA?
Salmeterol
Formoterol
Adverse effects of β2-agonists?
Tachycardia
Palpitations
Anxiety
Tremor
Promote glycogenolysis →increase serum glucose conc
At high doses →serum lactate may rise
LABA -muscle cramps
Warnings of β2-agonists?
ALWAYS offer LABA + ICS
- LABA alone is associated with increased asthma deaths.
CVD pts:
- tachycardia may provoke angina/arrhythmias
→occurs in tx of hyperkalemia when high doses are given.
Important interactions of β2-agonists?
Effectiveness may be reduced by β-blockers.
Concomitant use of high-dose nebulised β2-agonists with theophylline and corticosteroids can cause hypokalemia
→ so monitor serum K conc
How are β2-agonists monitored?
Asthma:
- monitor disease severity by assessing their symptoms and serial measurements of PEFR (peak expiratory flow rate).
COPD:
- monitor disease severity by assessing their symptoms and exacerbation rate.
Patient education on β2-agonists?
Aim to make their airways relax and improve breathing.
Seek medical advice if they use the inhaler very frequently
- increase other tx (e.g. ICS) according to their written action plan.
Ensure they know how and when to take the inhaler (e.g. for acute episode, before exercise, or regular long-acting medication).
Multiple doses in a short time period can cause pt to feel shaky and anxious.
Indications of anti-muscarinics (short-acting and long-acting)?
Asthma:
- SAMA (relieve breathlessness during acute exacerbation; given in addition to SABA).
- LAMA (offered to pts one or more severe asthma exacerbation in the past year; given alongside ICS + LABA).
COPD:
- SAMA (relieve breathlessness during acute exacerbation/exercise).
- LAMA (prevent breathlessness and exacerbation)
Mechanism of action of anti-muscarinics?
BRONCHODILATORS
Anti-muscarinics bind to muscarinin receptor by acting as a competitive inhibitor of acetylcholine
→ increases HR and conduction
→ reduces smooth muscle tone and secretions from glands in the resp and GI tract
In the eye:
→ causes relaxation of the pupillary constrictor, hence results pupillary dilation.
→ causes relaxation of ciliary muscles, hence prevents accommodation.
Adverse effects of anti-muscarinics?
Irritation of resp tract:
- Nasopharyngitis
- Sinusitis
- Cough
GI disturbance:
- Dry mouth
- Constipation
- Urinary retention
Blurred vision
Headaches
Warnings of anti-muscarinics?
Use with caution in pts:
- susceptible to acute angle closure glaucoma (can increase intraocular pressure)
- with/at risk of arrhythmias/urinary retention
Important interactions on anti-muscarinics?
Not generally a problem due to LOW SYSTEMIC ABSORPTION.
Monitoring of anti-muscarinics?
Effectiveness assessed by:
- improvement of symptoms
- review PEFR (for asthma)
Check inhaler technique at every review and correct it to optimise potential tx benefits.